Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (03378)

DirectorFromToPosition(s)Release Date / Document LinksReason for Change
Xiao Jieyu08-Feb-26ED, CFO, BrdSec
01-Mar-2408-Feb-26NED, MbACDue to work adjustment, Ms. Xiao has been re-designated from a non-executive Director to an executive Director. Xiao has been appointed as the chief financial officer and secretary of the Board.
Zhang Hui08-Feb-26J-CoSec, CFO, V-GMMr. Zhang has resigned to pursue his other personal and career developments.